Vantrexa · Metastatic NSCLC
Restricted — potential adverse event
12-stage inquiry workflow (PRD §16). Advancing records an audit event.
Routine: 120 h target · Routine 120 h / Urgent 48 h / Critical 24 h
SLA hours
120
Elapsed
70 h
to response
Remaining
50 h
12 Feb 2026, 08:24 UTC
Received via Congress booth
Payer · United States
12 Feb 2026, 08:24 UTC
Triage and assignment
Urgency Routine · assigned to MI Americas
12 Feb 2026, 08:24 UTC
Escalated
Safety flag — routed to pharmacovigilance
15 Feb 2026, 06:24 UTC
Response sent
Custom response · quality review passed
17 Feb 2026, 08:24 UTC
SLA due (120 h)
Restricted record
No audit events for this record
Create, update, approve and export events appear here with user, timestamp, previous and new values.
Data lineage: MI inquiry platform (IRMS, INT-05) · received 12 Feb 2026 · hourly sync.